Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ASND | AMGN | GILD | BIIB | CELG |
Company | Ascendis Pharma ADR | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 151.00 | 337.03 | 84.39 | 200.57 | 108.01 |
High | 154.81 | 338.70 | 84.65 | 204.18 | 108.59 |
Low | 149.26 | 334.61 | 83.57 | 200.11 | 107.27 |
Last | 151.40 | 336.96 | 84.28 | 202.30 | 108.24 |
Change | +2.52 | +4.04 | +0.39 | +4.71 | +0.11 |
% Change | +1.69% | +1.21% | +0.46% | +2.38% | +0.10% |
Volume | 687,462 | 719,227 | 4,180,813 | 564,512 | 191,230,496 |
20-Day Average Volume | 951,986 | 1,714,423 | 6,451,617 | 799,820 | 16,188,930 |
Previous Close | 148.88 | 332.92 | 83.89 | 197.59 | 108.13 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | No |
Technicals | |||||
20-Day Moving Average | 131.41 | 329.65 | 80.10 | 201.67 | 108.17 |
20-Day Raw Stochastic | 92.77% | 91.15% | 95.18% | 73.36% | 63.25% |
20-Day Relative Strength | 65.34% | 58.60% | 72.87% | 47.10% | 64.69% |
Weighted Alpha | +41.55 | +27.76 | +19.27 | -20.85 | +46.30 |
Today's Opinion | 8% Buy | 96% Buy | 88% Buy | 88% Sell | 100% Buy |
Previous Opinion | 8% Buy | 88% Buy | 88% Buy | 100% Sell | 100% Buy |
Last Month's Opinion | 24% Buy | 88% Buy | 56% Buy | 88% Sell | 100% Buy |
Performance | |||||
5-Days | |||||
%Chg | +33.25% since 09/12/24 | +2.17% since 09/12/24 | +1.53% since 09/12/24 | +2.53% since 09/12/24 | -1.97% since 11/13/19 |
Low | 114.53 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 192.25 on 09/13/24 | 107.27 on 11/20/19 |
High | 154.81 on 09/19/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 204.18 on 09/19/24 | 110.53 on 11/14/19 |
1-Month | |||||
%Chg | +10.03% since 08/19/24 | +2.82% since 08/19/24 | +13.40% since 08/19/24 | -1.54% since 08/19/24 | +5.14% since 10/18/19 |
Low | 111.09 on 09/12/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 192.25 on 09/13/24 | 102.40 on 10/21/19 |
High | 154.81 on 09/19/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 207.59 on 08/21/24 | 110.70 on 11/13/19 |
3-Month | |||||
%Chg | +23.10% since 06/18/24 | +10.21% since 06/18/24 | +33.70% since 06/18/24 | -9.28% since 06/18/24 | +13.63% since 08/20/19 |
Low | 111.09 on 09/12/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 192.25 on 09/13/24 | 93.41 on 08/23/19 |
High | 154.81 on 09/19/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 238.00 on 07/12/24 | 110.70 on 11/13/19 |
6-Month | |||||
%Chg | +4.32% since 03/19/24 | +24.10% since 03/19/24 | +15.01% since 03/19/24 | -7.20% since 03/19/24 | +14.14% since 05/20/19 |
Low | 111.09 on 09/12/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
High | 156.84 on 04/10/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 238.00 on 07/12/24 | 110.70 on 11/13/19 |
Key Statistics | |||||
Market Capitalization, $K | 8,669,430 | 178,589,936 | 104,514,608 | 28,768,510 | 77,035,920 |
Shares Outstanding, K | 58,231 | 536,435 | 1,245,853 | 145,597 | 711,714 |
Annual Sales | 288,670,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
Annual Net Income | -521,070,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
Last Quarter Sales | 38,770,000 | 8,388,000,000 | 6,954,000,000 | 2,464,900,000 | 4,520,000,000 |
Last Quarter Net Income | -117,790,000 | 746,000,000 | 1,614,000,000 | 583,600,000 | 1,691,000,000 |
60-Month Beta | 0.63 | 0.61 | 0.18 | -0.06 | 1.41 |
Per-Share Information | |||||
Most Recent Earnings | -2.05 on 09/03/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 5.28 on 08/01/24 | 2.99 on 10/31/19 |
Latest Earnings Date | 11/05/24 | 10/29/24 | 11/05/24 | 08/01/24 | 10/31/19 |
Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 17.89 | 17.67 | 12.19 | 10.99 |